Case Study

A Nimble And Flexible Solution To Rescuing An Observational Study

Source: Novotech
GettyImages-1439492413 patient recruitment

Focused on developing therapies for cancer patients, a European Biotech was looking to improve patient recruitment efforts across more than 145 sites in North America and Europe for an observational retrospective study of therapies for relapsed or refractory diffuse large B cell lymphoma. In 2020, the sponsor engaged Novotech for regulatory and clinical study management for the expansion into Asia Pacific (APAC) – with the addition of new sites in Australia, South Korea, and Taiwan.

Discover how with strong local expertise and a flexible, nimble approach in accommodating the sponsor the team was able to facilitate rapid study start-up of APAC sites and recruitment of 500 patients to expedite the study’s global recruitment milestone and meet the FDA submission deadline.

access the Case Study!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Cell & Gene